Thromboembolism Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Thromboembolism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 29 trials

Recruiting
Not Applicable

Electrical Impedance Tomography for Assessment of Pulmonary Hypertension

Pulmonary HypertensionPulmonary Thromboembolisms
University of Sao Paulo General Hospital120 enrolled1 locationNCT07453017
Recruiting
Not Applicable

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Quality of Life (QOL)Exercise TherapyAnxiety Depression+7 more
Insel Gruppe AG, University Hospital Bern160 enrolled5 locationsNCT07143539
Recruiting

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Lung Cancer (Diagnosis)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
The First Hospital of Jilin University900 enrolled1 locationNCT07439991
Recruiting

Impact of COVID-19 Vaccines on Cerebrovascular Health

DementiaBrain DiseasesStroke, Ischemic+7 more
Chinese University of Hong Kong500 enrolled1 locationNCT04992195
Recruiting
Phase 3

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Metastatic Pancreatic CancerVenous ThromboembolismLocally Advanced Pancreatic Adenocarcinoma
Quercis Pharma AG480 enrolled3 locationsNCT06861088
Recruiting
Phase 2

Venous Thromboembolism Prevention in Outpatients With Glioma

GlioblastomaVenous ThromboembolismAstrocytoma
University of Vermont Medical Center40 enrolled1 locationNCT05683808
Recruiting
Not Applicable

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk100 enrolled1 locationNCT07270263
Recruiting

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

NSCLC (Advanced Non-small Cell Lung Cancer)Venous Thromboembolism (VTE)
University Of Perugia500 enrolled1 locationNCT07288632
Recruiting

Early Detection of CTEPH in Patients After APE

Chronic Pulmonary Thromboembolism
Institute of Health Information and Statistics of the Czech Republic500 enrolled10 locationsNCT06865326
Recruiting
Phase 4

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Head and Neck CancerVenous Thromboembolism
Kiranya Arnold76 enrolled1 locationNCT07189897
Recruiting
Not Applicable

Functional Pulmonary Capillary Surface Area in BPA for CTEPH

Pulmonary ThromboembolismsHypertension, Pulmonary
Jewish General Hospital40 enrolled1 locationNCT05719415
Recruiting

Heat Shock Protein 47 in Thrombosis

Venous Thromboembolism (VTE)Stroke (in Patients With Atrial Fibrillation)Acute Myocardial Infarction With ST Segment Elevation
University of Aarhus340 enrolled2 locationsNCT06731673
Recruiting
Not Applicable

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

SurgeryCancerVenous Thromboembolism+2 more
Medical University of South Carolina30 enrolled1 locationNCT06451003
Recruiting
Not Applicable

Glioblastoma Remote Monitoring and Care - Research Protocol

GlioblastomaVenous ThromboembolismSeizures
Case Comprehensive Cancer Center25 enrolled1 locationNCT06129760
Recruiting

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Lung CancerVenous ThromboembolismArterial Thromboembolism
Beijing Chao Yang Hospital2,400 enrolled5 locationsNCT06950697
Recruiting
Early Phase 1

Apixaban in Thrombocytopenia

ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Rushad Patell30 enrolled1 locationNCT06886516
Recruiting
Phase 4

Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events

Ulcerative ColitisThromboembolism
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa30 enrolled1 locationNCT05313620
Recruiting

DOAC in Chinese Patients With Atrial Fibrillation

Brain DiseasesAtrial FibrillationStroke+4 more
Chinese University of Hong Kong427 enrolled1 locationNCT05378035
Recruiting

Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department

Pulmonary Thromboembolisms
IRCCS Azienda Ospedaliero-Universitaria di Bologna500 enrolled1 locationNCT06761144
Recruiting
Phase 4

Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support

BleedingThromboembolismRespiratory Insufficiency+1 more
Medical University of Vienna90 enrolled1 locationNCT06442267